Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System

Clinical trial NCT03185988 · UNKNOWN

Trial details

NCT number: NCT03185988
Sponsor: Shen Lin
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Targeted Therapy HER2 Biliary Tract Cancer Esophageal Squamous Cell Carcinoma Colorectal Cancer

Start date: 2017-07-01
Primary completion: 2021-07-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.